secwatch.observer — SEC 8-K summary
======================================

Issuer:     MASIMO CORP (MASI)
CIK:        0000937556
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0000937556-24-000004
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Masimo reports preliminary Q4 2023 rev $541-551M; FY2024 rev guidance $2.045-2.165B
--------------------------------------------------------------------------------

- Preliminary Q4 2023 consolidated revenue $541M-$551M; healthcare segment $336M-$341M.
- Full-year 2023 consolidated revenue $2.041B-$2.051B; healthcare $1.272B-$1.277B.
- FY2024 guidance: consolidated revenue $2.045B-$2.165B; healthcare $1.345B-$1.385B.
- FY2024 GAAP EPS $1.91-$2.08; non-GAAP EPS (updated) $3.44-$3.60 (prior $3.00-$3.15).
- Non-healthcare revenue expected to decline in FY2024 ($700M-$780M vs ~$771M in 2023).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/937556/000093755624000004/0000937556-24-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/937556/000093755624000004/masi-20240110.htm
  HTML page:      https://secwatch.observer/filing/0000937556-24-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer